Glenmark Pharmaceuticals on Saturday said its wholly-owned arm Glenmark Life Sciences has filed preliminary papers for an initial public offer with market regulator Sebi. Glenmark Life Sciences has filed a Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (Sebi) for an initial public offer, according to a regulatory filing. The offer comprises fresh issue of up to Rs 1,160 crore and an offer for sale of up to 73,05,245 equity shares of Rs 2 each of Glenmark Life Sciences Ltd, by Glenmark Pharmaceuticals Ltd, the filing said. The board of directors of Glenmark Pharmaceuticals Ltd during its meeting on April 16 approved the offer for sale of up to 73,05,245 equity shares of Rs 2 apiece as part of the IPO.
Glenmark Pharma arm files papers for IPO
PTI
New Delhi |
Updated on
April 17, 2021
×
Glenmark Life Sciences Ltd to make fresh issue of up to ₹1,160 crore and OFS of up to 73,05,245 equity shares of ₹2 each
Glenmark Pharmaceuticals on Saturday said its wholly-owned arm Glenmark Life Sciences has filed preliminary papers for an initial public offer (IPO) with market regulator SEBI. Glenmark Life Sciences has filed a Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (Sebi) for an initial public offer, said a regulatory filing. The offer comprises a fresh issue of up to ₹1,160 crore and an offer-for-sale (OFS) of up to 73,05,245 equity shares of ₹2 each of Glenmark Life Sciences Ltd, by Glenmark Pharmaceuticals Ltd, the filing said.
Glenmark Pharma arm files paperwork for IPO with SEBI
Glenmark Life Sciences has filed a Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (Sebi) for an initial public offer, according to a regulatory filing
PTI | April 17, 2021 | Updated 15:51 IST
The offer comprises fresh issue of up to Rs 1,160 crore and an offer for sale of up to 73,05,245 equity shares of Rs 2 each of Glenmark Life Sciences Ltd
Glenmark Pharmaceuticals on Saturday said its wholly-owned arm Glenmark Life Sciences has filed preliminary papers for an initial public offer with market regulator Sebi.
Glenmark Life Sciences has filed a Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (Sebi) for an initial public offer, according to a regulatory filing.
Glenmark Pharma arm files papers for IPO with Sebi freepressjournal.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freepressjournal.in Daily Mail and Mail on Sunday newspapers.
IPO Alert: GR Infraprojects Ltd plans to raise Rs 1,000 crore via IPO
IPO Alert: GR Infraprojects Ltd plans to raise Rs 1,000 crore via IPO
Udaipur-based GR Infraprojects has filed its Draft Red Herring Prospectus (DRHP) with the market regulator SEBI for initial public offering (IPO). This road engineering, procurement and construction (EPC) company is looking to raise around Rs 800-Rs 1,000 crore.
The company is looking at raising Rs 800-Rs 1,000 crore as per sources. The company has experience in the design and construction of various road and highway projects across 15 states in India.
In the last three fiscal years, the companyâs revenue from operations increased from Rs 3,295 crore in fiscal 2018 to Rs 6,373 crore in fiscal 2020 at a CAGR of 39 per cent. Meanwhile, the profit for the year increased from Rs 413 crore in fiscal 2018 to Rs 799 crore in fiscal 2020 at a CAGR of 39 per cent. In addition, the companyâs EBITDA has grown at a CAGR of 46 per cent from fisc